These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2573002)
1. An approach to the development of drugs for appetite disorders. Morley JE Neuropsychobiology; 1989; 21(1):22-30. PubMed ID: 2573002 [TBL] [Abstract][Full Text] [Related]
2. Neuro-hormonal control of food intake: basic mechanisms and clinical implications. Konturek PC; Konturek JW; Cześnikiewicz-Guzik M; Brzozowski T; Sito E; Konturek SJ J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():5-25. PubMed ID: 16340035 [TBL] [Abstract][Full Text] [Related]
4. The mechanism of action for oxyntomodulin in the regulation of obesity. Wynne K; Field BC; Bloom SR Curr Opin Investig Drugs; 2010 Oct; 11(10):1151-7. PubMed ID: 20872318 [TBL] [Abstract][Full Text] [Related]
5. Gut hormones in the control of appetite. Murphy KG; Bloom SR Exp Physiol; 2004 Sep; 89(5):507-16. PubMed ID: 15184357 [TBL] [Abstract][Full Text] [Related]
6. The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Holden RJ; Pakula IS Med Hypotheses; 1996 Dec; 47(6):423-38. PubMed ID: 8961238 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of appetite suppression: implication for the treatment of obesity. Halford JC Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637 [TBL] [Abstract][Full Text] [Related]
8. Drug strategies for the treatment of obesity. Alemany M; Remesar X; Fernández-López JA IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679 [TBL] [Abstract][Full Text] [Related]
9. The pharmacologic approach to the treatment of obesity. Weiser M; Frishman WH; Michaelson MD; Abdeen MA J Clin Pharmacol; 1997 Jun; 37(6):453-73. PubMed ID: 9208352 [TBL] [Abstract][Full Text] [Related]
13. 5-HT(2C) receptor agonists and the control of appetite. Halford JC; Harrold JA Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
15. Nicotine improves obesity and hepatic steatosis and ER stress in diet-induced obese male rats. Seoane-Collazo P; Martínez de Morentin PB; Fernø J; Diéguez C; Nogueiras R; López M Endocrinology; 2014 May; 155(5):1679-89. PubMed ID: 24517227 [TBL] [Abstract][Full Text] [Related]
16. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite. Rodgers RJ; Holch P; Tallett AJ Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921 [TBL] [Abstract][Full Text] [Related]
17. Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior. Bojanowska E; Ciosek J Curr Neuropharmacol; 2016; 14(2):118-42. PubMed ID: 26549651 [TBL] [Abstract][Full Text] [Related]
18. Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight. Engeli S Handb Exp Pharmacol; 2012; (209):357-81. PubMed ID: 22249824 [TBL] [Abstract][Full Text] [Related]